SmallCap
CompaniesStatistics

주식회사 렉스팜텍

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name주식회사 렉스팜텍
Business Reg. No.1518601602
CEO유지석
Address경기 용인시
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products제제연구/분석연구/신약연구
EstablishedContact
Phone031-214-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.134511-*******

Investment Metrics


Market Cap
-
Op. Margin
15.23%
ROE
25.29%
Debt Ratio
59.02%

Certification Status


Venture Certified

Cert. History
기술평가대출기업(중진공)2020-04-24 ~ 2022-04-23202004008492020-04-24
연구개발유형2022-06-22 ~ 2025-06-21202206220200272020-04-24
연구개발유형2025-06-22 ~ 2028-06-21202507230200062020-04-24

Financial Statements


3-Year Financial Data

Revenue CAGR +44.5%

Item202420232022
Revenue

68.5B

37.9B

32.8B

Operating Profit

10.4B

2.7B

6.9B

Net Profit

10.0B

2.5B

6.9B

Total Assets

62.9B

36.8B

36.6B

Total Liabilities

23.4B

6.9B

9.1B

Total Equity

39.6B

29.9B

27.5B

Risk Indicators


1 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
68B

93.7%

vs. 3-Year Avg.: 35B
Operating Profit
10B

117.0%

vs. 3-Year Avg.: 5B
Op. Margin
15.2%

8.0%

vs. 3-Year Avg.: 14.1%
Debt Ratio
59.0%

110.3%

vs. 3-Year Avg.: 28.1%
ROE
25.3%

52.2%

vs. 3-Year Avg.: 16.6%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
유지석대표이사대표

Employment Status


Regular EmployeesContact
CEO유지석

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "경기 용인시",
  "ceo_name": "유지석",
  "certificate": [
    {
      "cert_number": "20200400849",
      "changes": "",
      "disclosure_date": "2020-04-24",
      "first_cert_date": "2020-04-24",
      "no": "1",
      "type": "기술평가대출기업(중진공)",
      "valid_period": "2020-04-24 ~ 2022-04-23"
    },
    {
      "cert_number": "20220622020027",
      "changes": "",
      "disclosure_date": "2022-06-22",
      "first_cert_date": "2020-04-24",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2022-06-22 ~ 2025-06-21"
    },
    {
      "cert_number": "20250723020006",
      "changes": "",
      "disclosure_date": "2025-07-23",
      "first_cert_date": "2020-04-24",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2025-06-22 ~ 2028-06-21"
    }
  ],
  "company_name": "주식회사 렉스팜텍",
  "corp_no": "134511-*******",
  "financials": {
    "2022": {
      "capital_stock": 250000000,
      "cost_of_sales": 0,
      "current_assets": 2606523000,
      "current_liabilities": 453752000,
      "gross_profit": 3279500000,
      "net_income": 686745000,
      "net_income_bs": 676124000,
      "non_current_assets": 1053858000,
      "non_current_liabilities": 457760000,
      "non_operating_expenses": 7500000,
      "non_operating_income": 536000,
      "operating_profit": 693709000,
      "revenue": 3279500000,
      "sga_expenses": 2585791000,
      "total_assets": 3660381000,
      "total_equity": 2748869000,
      "total_liabilities": 911512000
    },
    "2023": {
      "capital_stock": 250000000,
      "cost_of_sales": 0,
      "current_assets": 2525249000,
      "current_liabilities": 246137000,
      "gross_profit": 3789006000,
      "net_income": 247352000,
      "net_income_bs": 244064000,
      "non_current_assets": 1155021000,
      "non_current_liabilities": 441200000,
      "non_operating_expenses": 28388000,
      "non_operating_income": 8784000,
      "operating_profit": 266956000,
      "revenue": 3789006000,
      "sga_expenses": 3522050000,
      "total_assets": 3680270000,
      "total_equity": 2992933000,
      "total_liabilities": 687337000
    },
    "2024": {
      "capital_stock": 250000000,
      "cost_of_sales": 0,
      "current_assets": 5354432000,
      "current_liabilities": 1811033000,
      "gross_profit": 6845150000,
      "net_income": 1000768000,
      "net_income_bs": 963740000,
      "non_current_assets": 937414000,
      "non_current_liabilities": 524140000,
      "non_operating_expenses": 45419000,
      "non_operating_income": 3973000,
      "operating_profit": 1042214000,
      "revenue": 6845150000,
      "sga_expenses": 5802936000,
      "total_assets": 6291846000,
      "total_equity": 3956673000,
      "total_liabilities": 2335173000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "제제연구/분석연구/신약연구",
  "phone": "031-214-****",
  "years": [
    2024,
    2023,
    2022
  ]
}